Article Details
Retrieved on: 2022-11-10 05:57:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biopharma firm, which is developing ZB001 in China for the treatment of Thyroid Eye Disease (TED), raised the new proceeds from lead investor ...
Article found on: www.dealstreetasia.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here